OncoSec Medical Incorporated
ONCSQ
$0.00
$0.000.00%
OTC PK
| 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.01M | 2.54M | 2.81M | 2.52M | 2.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.66M | 7.31M | 8.13M | 9.55M | 9.42M |
| Operating Income | -7.66M | -7.31M | -8.13M | -9.55M | -9.42M |
| Income Before Tax | -6.86M | -8.06M | -8.22M | -9.58M | -9.90M |
| Income Tax Expenses | 3.00K | -- | 0.00 | -3.34M | 3.00K |
| Earnings from Continuing Operations | -6.86M | -8.06M | -8.22M | -6.25M | -9.91M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.86M | -8.06M | -8.22M | -6.25M | -9.91M |
| EBIT | -7.66M | -7.31M | -8.13M | -9.55M | -9.42M |
| EBITDA | -7.60M | -7.24M | -8.07M | -9.48M | -9.35M |
| EPS Basic | -2.65 | -4.50 | -4.59 | -3.49 | -5.54 |
| Normalized Basic EPS | -1.66 | -2.81 | -2.87 | -3.35 | -3.46 |
| EPS Diluted | -2.65 | -4.50 | -4.59 | -3.49 | -5.54 |
| Normalized Diluted EPS | -1.66 | -2.81 | -2.87 | -3.35 | -3.46 |
| Average Basic Shares Outstanding | 2.59M | 1.79M | 1.79M | 1.79M | 1.79M |
| Average Diluted Shares Outstanding | 2.59M | 1.79M | 1.79M | 1.79M | 1.79M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |